Publications by authors named "Mark Quinn"

Claim this Profile
T
The Concise Guide to PHARMACOLOGY 2025/26: G protein-coupled receptors.
Stephen P H Alexander, Anthony P Davenport, Eamonn Kelly, Alasdair J Gibb, Alistair A Mathie, Mark Quinn

Br J Pharmacol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved Lung Function With Cyclophosphamide and Rituximab in a Case of Shrinking Lung Syndrome.
Shiza Chaudhry, Haider Bokhary, Mark Quinn

Cureus· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, Synthesis, and Biological Evaluation of Novel Heteroaryl, Squaramide, and Indolcarboxamide Derivatives as Formyl Peptide Receptor 2 Agonists to Target Neuroinflammation.
Fabio Francavilla, Daniele Vitone, Igor A Schepetkin, Lilya N Kirpotina, Antonio Carrieri, Mark T Quinn

ACS Chem Neurosci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of human infection challenge studies (HICs) in drug development for respiratory syncytial virus (RSV): systematic review and meta-analysis.
Prosenjit Kundu, Mark Quinn, Elaine Thomas, Jared C Christensen, Sima S Toussi

EBioMedicine· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydrogen Sulfide (HS)-Donating Formyl Peptide Receptor 2 (FPR2) Agonists: Design, Synthesis, and Biological Evaluation in Primary Mouse Microglia Culture.
Leonardo Brunetti, Fabio Francavilla, Mauro Niso, Jakub Kosma Frydrych, Ewa Trojan, Mark T Quinn

Antioxidants (Basel)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tricyclic Isatin Derivatives as Anti-Inflammatory Compounds with High Kinase Binding Affinity.
Alexander V Uvarov, Igor A Schepetkin, Mark T Quinn, Andrei I Khlebnikov

Molecules· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimisation of an nIR-Emitting Benzoporphyrin Pressure-Sensitive Paint Formulation.
Elliott J Nunn, Louise S Natrajan, Mark K Quinn

Sensors (Basel)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical, genetic, radiological characteristics and management of mediastinal paragangliomas: a literature review and case series.
Mark Quinn, Yasmine Kemkem, Gemma White, Phil Touska, Dimitra Christodoulou

Endocr Relat Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of bright NIR-emitting pressure-sensitive paints using benzoporphyrin luminophores.
Elliott J Nunn, Dimitrios Tsioumanis, Tom B Fisher, David A Roberts, Mark K Quinn

Chem Sci· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of small-molecule fluorescent probes targeting neutrophils -formyl peptide receptors.
Qi Xu, Kalwant S Authi, Liliya N Kirpotina, Igor A Schepetkin, Mark T Quinn

RSC Med Chem· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simulation of Flow Around a Finite Rectangular Prism: Influence of Mesh, Model, and Subgrid Length Scale.
Xutong Zhang, Maxime Savoie, Mark K Quinn, Ben Parslew, Alistair Revell

Entropy (Basel)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tuning the Performance of Metalloporphyrin-Based Pressure-Sensitive Paints through the Nature of the Central Metal Ion.
Elliott J Nunn, Dimitrios Tsioumanis, George F S Whitehead, Tom B Fisher, David A Roberts, Mark K Quinn

ACS Omega· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes in patients with COPD treated with non-invasive ventilation for acute hypercapnic respiratory failure.
Shane O'Brien, Cara Gill, Niall Cograve, Mark Quinn, Ruairi J Fahy

Ir J Med Sci· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phytochemical Composition and Biological Activity of the Essential Oil from Collected in Southwestern Montana, United States.
Igor A Schepetkin, Gulmira Özek, Temel Özek, Liliya N Kirpotina, Andrei I Khlebnikov, Mark T Quinn

Plants (Basel)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-Inflammatory Activity of Pyrazolo[1,5-]quinazolines.
Letizia Crocetti, Andrei I Khlebnikov, Gabriella Guerrini, Igor A Schepetkin, Fabrizio Melani, Mark T Quinn

Molecules· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ebselen analogues with dual human neutrophil elastase (HNE) inhibitory and antiradical activity.
Letizia Crocetti, Francesca Catarzi, Maria Paola Giovannoni, Claudia Vergelli, Gianluca Bartolucci, Mark T Quinn

RSC Med Chem· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of potent isoflavone-based formyl peptide receptor 1 (FPR1) antagonists and their effects in gastric cancer cell models.
Fabio Francavilla, Federica Sarcina, Igor A Schepetkin, Lilya N Kirpotina, Marialessandra Contino, Mark T Quinn

Eur J Med Chem· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comprehensive characterisation of phaeochromocytoma and paraganglioma tumours through histone protein profiling, DNA methylation and transcriptomic analysis genome wide.
Prodromos Chatzikyriakou, Dimitria Brempou, Mark Quinn, Lauren Fishbein, Roberta Noberini

Clin Epigenetics· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Volatile Composition, Antimicrobial Activity, and In Vitro Innate Immunomodulatory Activity of (L.) Moench Essential Oils.
Noura S Dosoky, Liliya N Kirpotina, Igor A Schepetkin, Andrei I Khlebnikov, Brent L Lisonbee, Mark T Quinn

Molecules· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors.
Stephen P H Alexander, Arthur Christopoulos, Anthony P Davenport, Eamonn Kelly, Alistair A Mathie, Mark Quinn

Br J Pharmacol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomodulatory Activity of Polysaccharides Isolated from L. and Ledeb.
Igor A Schepetkin, Marina G Danilets, Anastasia A Ligacheva, Evgenia S Trofimova, Natalia S Selivanova, Mark T Quinn

Molecules· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Composition and Biological Activity of the Essential Oils from Wild Horsemint, Yarrow, and Yampah from Subalpine Meadows in Southwestern Montana: Immunomodulatory Activity of Dillapiole.
Igor A Schepetkin, Gulmira Özek, Temel Özek, Liliya N Kirpotina, Robyn A Klein, Mark T Quinn

Plants (Basel)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuroprotective Effects of Tryptanthrin-6-Oxime in a Rat Model of Transient Focal Cerebral Ischemia.
Mark B Plotnikov, Galina A Chernysheva, Vera I Smol'yakova, Oleg I Aliev, Anna M Anishchenko, Mark T Quinn

Pharmaceuticals (Basel)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating the Prevalence of AATD Patients in the UK to Identify Underdiagnosis and Determine the Eligibility for Potential Augmentation Therapy.
Michael Newnham, Mark Quinn, Alice M Turner

Int J Chron Obstruct Pulmon Dis· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Tryptanthrin Derivatives with Selectivity as -Jun N-Terminal Kinase (JNK) 3 Inhibitors.
Igor A Schepetkin, Oleksander S Karpenko, Anastasia R Kovrizhina, Liliya N Kirpotina, Andrei I Khlebnikov, Mark T Quinn

Molecules· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis